Human Genome Epidemiology Literature Finder
|
Records 1 - 30 (of 1817 Records) |
| Query Trace: Adenocarcinoma and EGFR[original query] |
|---|
| Prognostic Significance of Volumetric Parameters Based on FDG PET/CT in Patients with Lung Adenocarcinoma Undergoing Curative Surgery. Cancers 2023 9 15 (17): . Hyunjong Lee, Yoon-La Choi, Hong Kwan Kim, Yong Soo Choi, Hojoong Kim, Myung-Ju Ahn, Hong Ryul Pyo, Joon Young Ch |
| [Clinical characteristics and their influences on the survival of leptomeningeal metastasis derived from lung adenocarcinoma harboring epithelial growth factor receptor mutation]. Zhonghua yi xue za zhi 2023 9 103 (34): 2713-2719. A F Jiang, S S Zhou, Q Zhou, J Zhao, X P Li, R R Zhou, B |
| Effects of concurrent TP53 mutations on the efficacy and prognosis of targeted therapy for advanced EGFR mutant lung adenocarcinoma. Cancer genetics 2023 9 278-279 62-70. Huiwen Qian, Chunqi Hou, Yi Zhang, Shundong Ji, Chongke Zhong, Juan Li, Qianqian Zhang, Jianan Huang, Chong Li, Cheng |
| Study on the application of percutaneous closed pleural brushing combined with cell block technique in the diagnosis of malignant pleural effusion. The clinical respiratory journal 2023 9 . Kang Wang, Xueting Hu, Yufang Chen, Xinglin Yi, Xianfeng Han, Duan Zhu, Bingjing Zhu, Hu L |
| Unveiling the metal mutation nexus: Exploring the genomic impacts of heavy metal exposure in lung adenocarcinoma and colorectal cancer. Journal of hazardous materials 2023 9 461 132590. Mengyuan Liu, Yuting Hong, Xiaohong Duan, Qiming Zhou, Jing Chen, Siyao Liu, Junyan Su, Li Han, Jiali Zhang, Beifang N |
| Association between Contrast-Enhanced Computed Tomography Radiomic Features, Genomic Alterations and Prognosis in Advanced Lung Adenocarcinoma Patients. Cancers 2023 9 15 (18): . Lisa Rinaldi, Elena Guerini Rocco, Gianluca Spitaleri, Sara Raimondi, Ilaria Attili, Alberto Ranghiero, Giulio Cammarata, Marta Minotti, Giuliana Lo Presti, Francesca De Piano, Federica Bellerba, Gianluigi Funicelli, Stefania Volpe, Serena Mora, Cristiana Fodor, Cristiano Rampinelli, Massimo Barberis, Filippo De Marinis, Barbara Alicja Jereczek-Fossa, Roberto Orecchia, Stefania Rizzo, Francesca Bot |
| Effect of Different Timing of Local Brain Radiotherapy on Survival of EGFR-Mutated NSCLC Patients with Limited Brain Metastases. Brain sciences 2023 9 13 (9): . Yu Wang, Shenghong Wu, Jing Li, Xiaohua Liang, Xinli Zh |
| Concordance of Abundance for Mutational EGFR and Co-Mutational TP53 with Efficacy of EGFR-TKI Treatment in Metastatic Patients with Non-Small-Cell Lung Cancer. Current oncology (Toronto, Ont.) 2023 9 30 (9): 8464-8476. Youping Wang, Hong Liu, Ningjuan Yu, Xueping Xia |
| Computed Tomography-derived intratumoral and peritumoral radiomics in predicting EGFR mutation in lung adenocarcinoma. La Radiologia medica 2023 9 . Youlan Shang, Weidao Chen, Ge Li, Yijie Huang, Yisong Wang, Xiaoyan Kui, Ming Li, Hairong Zheng, Wei Zhao, Jun L |
| Exploring the molecular features and genetic prognostic factors of pulmonary high-grade neuroendocrine carcinomas. Human pathology 2023 9 . Haiyue Wang, Linghua Yan, Yanli Zhu, Wei Sun, Xin Yang, Xinying Liu, Kaiwen Chi, Xiaozheng Huang, Lixin Zhou, Dongmei L |
| EGFR mutation testing from pleural effusions of non-small cell lung cancer patients at the institute for oncology and radiology of Serbia. Translational oncology 2023 9 37 101772. Miodrag Vukovic, Miljana Tanic, Ana Damjanovic, Marijana Pavlovic, Aleksandra Stanojevic, Katarina Zivic, Valentina Karadzic, Radmila Jankovic, Milena Cav |
| Successful treatment of lung adenocarcinoma complicated with a rare compound EGFR mutation L833V/H835L using aumolertinib: a case report and literature review. Frontiers in pharmacology 2023 9 14 1257592. Linlin Li, Siyuan Huang, Liying Qin, Ningning Yan, Shujing Shen, Xingya |
| Upfront liquid next-generation sequencing in treatment-naïve advanced non-small cell lung cancer patients: A prospective randomised study in the Taiwanese health system. European journal of cancer (Oxford, England : 1990) 2023 9 193 113310. Ching-Yao Yang, Jin-Yuan Shih, Wei-Yu Liao, Chao-Chi Ho, Chia-Lin Hsu, Tzu-Hsiu Tsai, Shang-Gin Wu, Yen-Ting Lin, Wei-Hsun Hsu, Suyog Jain, Steve Olsen, James Chih-Hsin Yang, Chong-Jen Yu, Pan-Chyr Ya |
| Clinico-pathological characteristics of IGFR1 and VEGF-A co-expression in early and locally advanced-stage lung adenocarcinoma. Journal of cancer research and clinical oncology 2023 9 . Wenting Liu, Junling Xia, Qingwu Du, Jingya Wang, Ting Mei, Tingting Q |
| Whole exome sequencing and MicroRNA profiling of lung adenocarcinoma identified risk prediction features for tumors at stage I and its substages. Lung cancer (Amsterdam, Netherlands) 2023 9 184 107352. Hao Ho, Sung-Liang Yu, Hsuan-Yu Chen, Shin-Sheng Yuan, Kang-Yi Su, Yi-Chiung Hsu, Chung-Ping Hsu, Cheng-Yen Chuang, Ya-Hsuan Chang, Yu-Cheng Li, Chiou-Ling Cheng, Gee-Chen Chang, Pan-Chyr Yang, Ker-Chau |
| Transcriptional analysis of landmark molecular pathways in lung adenocarcinoma results in a clinically relevant classification with potential therapeutic implications. Molecular oncology 2023 11 . Sara Hijazo-Pechero, Ania Alay, David Cordero, Raúl Marín, Noelia Vilariño, Ramón Palmero, Jesús Brenes, Aina Montalban-Casafont, Ernest Nadal, Xavier So |
| Comparison of gene mutation profile in different lung adenocarcinoma subtypes by targeted next-generation sequencing. Medical oncology (Northwood, London, England) 2023 11 40 (12): 349. Shaowen Zhang, Ping Dong, Zongwei Pan, Qian Chen, Junqi Zhu, Zhangfan M |
| PDL1 and molecular biomarkers expression in non-small cell lung cancer in Tunisian patients. Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace 2023 11 . Yoldez Houcine, Chirine Moussa, Ahmed Ben Abdelaziz, Aida Aya |
| Long-term follow-up of a consecutive cohort validating an epidermal growth factor receptor mutation as an independent risk factor for postoperative recurrence in lung adenocarcinoma. Interdisciplinary cardiovascular and thoracic surgery 2023 11 37 (5): . Yuki Matsumura, Kazuki Hayasaka, Tetsuya Ohira, Satoshi Shiono, Jiro Abe, Hirotsugu Notsuda, Akira Sakurada, Hiroyuki Suzuki, Yoshinori Oka |
| Correlation analysis of clinical, pathological, imaging and genetic features of ground-glass nodule featured lung adenocarcinomas between high-risk and non-high-risk individuals. European journal of medical research 2023 11 28 (1): 478. Jing Ren, Yuan Wang, Chunrong Liu, Lan Yang, Xinlu Men, Zhixin Q |
| DNA damage response and repair gene mutations are associated with tumor mutational burden and outcomes to platinum-based chemotherapy/immunotherapy in advanced NSCLC patients. Diagnostic pathology 2023 11 18 (1): 119. Weiguang Gu, Wenya Zhuang, Mengxia Zhuang, Minhong He, Zhihua |
| Prognostic Outcomes and Recurrence Patterns in Resected Stage I Lung Adenocarcinoma Harboring Atypical Epidermal Growth Factor Receptor Mutation. European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery 2023 11 . Tao Chen, Jialiang Wen, Yingze Li, Jiajun Deng, Yifan Zhong, Likun Hou, Yunlang She, Dong Xie, Chang Ch |
| Peritumoural MRI radiomics signature of brain metastases can predict epidermal growth factor receptor mutation status in lung adenocarcinoma. Clinical radiology 2023 11 . Z Huang, X Tu, T Yu, Z Zhan, Q Lin, X Hua |
| Clinical, Genomic, and Transcriptomic Featurses of Lung Adenocarcinoma With Uncommon EGFR Mutation. Clinical lung cancer 2023 11 . Kazuki Hayasaka, Haruna Takeda, Akira Sakurada, Yuki Matsumura, Jiro Abe, Satoshi Shiono, Hirotsugu Notsuda, Hiroyuki Suzuki, Makoto Endo, Hozumi Motohashi, Yoshinori Oka |
| Pulmonary Low Malignant Potential Adenocarcinoma: A Validation of the Proposed Criteria for This Novel Subtype. The American journal of surgical pathology 2023 11 . Alessandra Pittaro, Filippo Crivelli, Giulia Orlando, Francesca Napoli, Vanessa Zambelli, Francesco Guerrera, Simona Sobrero, Marco Volante, Luisella Righi, Mauro Papot |
| Efficacy and safety of anti-programmed cell death protein 1 antibody combination therapy in patients with advanced experienced epidermal growth factor receptor-tyrosine kinase inhibitor-resistant lung adenocarcinoma: a retrospective cohort study. Journal of thoracic disease 2023 11 15 (10): 5648-5657. Chang Wan, Yiruo Zhang, Pingping Liu, Xinkuan Mei, Gang Cheng, Jingdan Pang, Sheng Chen, Jianping Xu, Jyoti Malhotra, Hesheng Qian, Yingying |
| Systematic evaluation of clinical efficacy of CYP1B1 gene polymorphism in EGFR mutant non-small cell lung cancer observed by medical image. Open life sciences 2023 10 18 (1): 20220688. Shaofeng Zhang, Danqing Li, Xia H |
| Cerebrospinal fluid circulating tumour DNA genotyping and survival analysis in lung adenocarcinoma with leptomeningeal metastases. Journal of neuro-oncology 2023 10 . Kaixuan Bai, Xin Chen, Xuejiao Qi, Yu Zhang, Yueli Zou, Jian Li, Lili Yu, Yuanyuan Li, Jiajia Jiang, Yi Yang, Yajing Liu, Shuanghao Feng, Hui |
| Sequential treatment in advanced epidermal growth factor receptor-mutated lung adenocarcinoma patients receiving first-line bevacizumab combined with 1st/2nd-generation EGFR-tyrosine kinase inhibitors. Frontiers in oncology 2023 10 13 1249106. Ping-Chih Hsu, Chun-Yao Huang, Yu-Ching Lin, Suey-Haur Lee, Li-Chung Chiu, Chiao-En Wu, Scott Chih-Hsi Kuo, Jia-Shiuan Ju, Allen Chung-Cheng Huang, Ho-Wen Ko, Chin-Chou Wang, Cheng-Ta Ya |
| Therapeutic impact of epidermal growth factor receptor tyrosine kinase inhibitor with various treatment combinations for advanced lung adenocarcinoma. World journal of surgical oncology 2023 10 21 (1): 326. Ying-Yi Chen, Kuan-Hsun Lin, Yen-Shou Kuo, Yuan-Ming Tsai, Hsu-Kai Huang, Tsai-Wang Hua |
- Page last reviewed:Oct 1, 2023
- Page last updated:Dec 01, 2023
- Content source: